These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1354841)

  • 1. Heterologous desensitization of the human dopamine D1 receptor in Y1 adrenal cells and in a desensitization-resistant Y1 mutant.
    Olson MF; Schimmer BP
    Mol Endocrinol; 1992 Jul; 6(7):1095-102. PubMed ID: 1354841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of adenylyl cyclase activity by beta-adrenergic agonists in a desensitization-resistant mutant cell line.
    Olson MF; Tsao J; Pon DJ; Schimmer BP
    Mol Endocrinol; 1991 Jan; 5(1):34-41. PubMed ID: 1850109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist-induced desensitization of adenylyl cyclase in Y1 adrenocortical tumor cells.
    Olson MF; Tsao J; Pon DJ; Schimmer BP
    Endocr Res; 1991; 17(1-2):19-42. PubMed ID: 1679008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations to forskolin resistance result in loss of adrenocorticotropin receptors and consequent reductions in levels of G protein alpha-subunits.
    Qiu R; Tsao J; Kwan WK; Schimmer BP
    Mol Endocrinol; 1996 Dec; 10(12):1708-18. PubMed ID: 8961279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist-induced desensitization of D1-dopamine receptors linked to adenylyl cyclase activity in cultured NS20Y neuroblastoma cells.
    Barton AC; Sibley DR
    Mol Pharmacol; 1990 Oct; 38(4):531-41. PubMed ID: 1978240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta 1-adrenergic and dopamine (D1)-receptors coupled to adenylyl cyclase activation in GT1 gonadotropin-releasing hormone neurosecretory cells.
    Findell PR; Wong KH; Jackman JK; Daniels DV
    Endocrinology; 1993 Feb; 132(2):682-8. PubMed ID: 8093877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenocorticotropin-resistant mutants of the Y1 adrenal cell line fail to express the adrenocorticotropin receptor.
    Schimmer BP; Kwan WK; Tsao J; Qiu R
    J Cell Physiol; 1995 Apr; 163(1):164-71. PubMed ID: 7896893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist-induced desensitization of D2 dopamine receptors in human Y-79 retinoblastoma cells.
    Barton AC; Black LE; Sibley DR
    Mol Pharmacol; 1991 May; 39(5):650-8. PubMed ID: 1674585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor-G-protein coupling in desensitization-resistant mutant adrenal cells.
    Olson MF; Schimmer BP
    Endocrinology; 1994 Jan; 134(1):7-10. PubMed ID: 7903937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of beta-agonist- and prostaglandin E2-mediated adenylyl cyclase activity in human airway epithelial cells.
    Penn RB; Kelsen SG; Benovic JL
    Am J Respir Cell Mol Biol; 1994 Oct; 11(4):496-505. PubMed ID: 7917318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
    Zeiders JL; Seidler FJ; Slotkin TA
    J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desensitization of adenylate cyclase and down regulation of beta adrenergic receptors after in vivo administration of beta agonist.
    Scarpace PJ; Abrass IB
    J Pharmacol Exp Ther; 1982 Nov; 223(2):327-31. PubMed ID: 6127402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
    O'Sullivan GJ; Roth BL; Kinsella A; Waddington JL
    Eur J Pharmacol; 2004 Feb; 486(3):273-80. PubMed ID: 14985049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grooming and vacuous chewing induced by SK&F 83959, an agonist of dopamine 'D1-like' receptors that inhibits dopamine-sensitive adenylyl cyclase.
    Downes RP; Waddington JL
    Eur J Pharmacol; 1993 Mar; 234(1):135-6. PubMed ID: 8097163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
    Roseboom PH; Gnegy ME
    Mol Pharmacol; 1989 Jan; 35(1):139-47. PubMed ID: 2563306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells.
    Grenader A; Healy DP
    J Pharmacol Exp Ther; 1991 Jul; 258(1):193-8. PubMed ID: 1677038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of responsiveness at D2 dopamine receptors by receptor desensitization and adenylyl cyclase sensitization.
    Bates MD; Senogles SE; Bunzow JR; Liggett SB; Civelli O; Caron MG
    Mol Pharmacol; 1991 Jan; 39(1):55-63. PubMed ID: 1846220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human chorionic gonadotropin-induced heterologous desensitization of rabbit luteal adenylyl cyclase is associated with altered receptor and G-protein function.
    Jena BP; Abramowitz J
    Endocrinology; 1989 Apr; 124(4):1932-41. PubMed ID: 2538314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dopamine receptor in the intermediate lobe of the rat pituitary gland: pharmacological characterization.
    Munemura M; Cote TE; Tsuruta K; Eskay RL; Kebabian JW
    Endocrinology; 1980 Dec; 107(6):1676-83. PubMed ID: 6107242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered G protein activity in a desensitization-resistant mutant of the Y1 adrenocortical tumor cell line.
    Colantonio CM; Kwan WK; Czerwinski W; Mitchell J; Schimmer BP
    Endocrinology; 1998 Feb; 139(2):626-33. PubMed ID: 9449634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.